China SXT Pharmaceuticals Inc Shares Close the Day 11.5% Lower - Daily Wrap
The company saw its shares close the day 11.5% lower than yesterday, with trading volume higher than its 30 day average.
Jan 07, 2022 by Kwhen Finance Editors
China SXT Pharmaceuticals Inc (SXTC) shares closed today 11.5% lower than it did at the end of yesterday. The stock is currently down 6.2% year-to-date, down 67.9% over the past 12 months, and down 97.3% over the past five years. Today, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 0.1%.
Trading Activity
- Shares traded as high as $0.74 and as low as $0.51 this week.
- Shares closed 89.5% below its 52-week high and 6.9% above its 52-week low.
- Trading volume this week was 41.8% lower than the 10-day average and 11.1% higher than the 30-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 1.6.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance
- The company's share price lags the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price lags the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price lags the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| China SXT Pharmaceuticals Inc | -11.5 | -6.2 | -67.9 | -88.2 | 19.3 |
| Dow Jones Industrial Average | -0.5 | 0.2 | 21.9 | -1.4 | 24.0 |
| S&P 500 Index | -0.1 | -1.4 | 27.8 | -2.5 | 28.8 |
| Health Care | -1.1 | -3.5 | 19.1 | -4.6 | 22.5 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by 78.8%
- The company's stock price performance over the past 12 months lags the peer average by 261.4%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| China SXT Pharmaceuticals Inc | SXTC | 0 | -6.2 | -67.9 | -88.2 | 19.3 |
| Peer Avg | N/A | 10.1 | -3.5 | -18.8 | -30.0 | 9.9 |
| Opko Health Inc | OPK | 40.4 | -6.4 | 5.9 | -28.2 | 38.0 |
| Onconova Therapeutics Inc | ONTX | 0 | -7.5 | -81.0 | -91.8 | 1.7 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: